FDA to hold meeting on CAD fetal monitors

The FDA is seeking feedback on evaluating and improving the effectiveness of fetal monitors that use computer-aided detection (CAD) technology.

To evaluate the technology, the agency is holding a free all-day workshop on the subject on Nov. 10 at its Silver Spring, Md., campus.

Attendees will discuss how to identify and differentiate the various categories of the devices and the corresponding levels of evidence needed to validate them. Participants also will discuss how current databases might be used to verify and validate algorithms for the devices.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.